Worried about RSV?

Contact a clinical trial site and get tested today at no cost to see if you qualify for the study

Indago Research

786-772-0510

3700 W 12th ave, suite 300 Hialeah FL 33012

RSV can be a serious, life-threatening virus for high-risk adults who are 18 years or older and meet at least 1 of the following criteria:

  • Moderate or severe COPD
  • Asthma
  • Chronic lung disease
  • Chronic cardiovascular disease
  • ≥60 years of age (vaccinated or nonvaccinated)

Why join an RSV clinical trial?

Access to an investigational oral medication for RSV

  • Limited treatment options for high-risk adults
  • No FDA-approved oral treatment available
  • Don’t have to discontinue current medications to participate

It’s important to get your RSV status confirmed quickly.

To be eligible for the study, you must be diagnosed with RSV and enrolled within 3 days of your symptoms starting.

 

We are looking for people who are affected by both hypertension and chronic kidney disease to participate in a research study to investigate a new experimental treatment. The research study is called EXPLORE-CKD

You may qualify if you:

  • Have been diagnosed with hypertension and chronic kidney disease
  • Are taking medication for hypertension
  • Have abnormal kidney tests showing too much albumin (a type of protein) in your urine

Consider participating in the EXPLORE-CKD research study for a chance to contribute to research that may lead to more effective treatment options for high blood pressure and chronic kidney disease.

Choosing to participate in a clinical research study is an important decision. The information obtained from the EXPLORE-CKD study may help advance the treatment of future patients with high blood pressure and chronic kidney disease; and will provide important information about how well people respond to the study drug being investigated.

All clinical research studies are highly regulated to try to protect your safety and human rights. The research team can help explain this to you in further detail so that you are fully informed about the study before you decide whether you would like to participate.

What do I do next?

The EXPLORE-CKD Clinical Study is currently looking for interested study participants.

FOR MORE INFORMATION

786-772-0510

Active-controlled study to assess the efficacy, safety, and tolerability of investigational drug Baxdrostat in combination with Dapagliflozin compared with Dapagliflozin alone on chronic kidney disease (CKD) progression in participants with CKD and high blood pressure.

ACHIEVE-4 is a clinical research study for people with type 2 diabetes and excess weight who are at risk for heart disease or stroke. The study will test how safe and well the investigational medicine (the medicine being studied) works for blood glucose and weight management compared with insulin therapy.

Can I join this study?

Yes, you may be able to join the research study if you:

  • Are aged 18 years or over
  • Have type 2 diabetes
  • Take at least 1 medicine to manage your diabetes
  • Have a BMI* of 25 or higher
  • Have or are at risk for heart disease, stroke, or other blood vessel diseases, or have kidney disease

*BMI stands for body mass index. If you do not know your BMI, please contact a healthcare professional.

 

 

    • VA: Greetings, I am Indago's Virtual Assistant. Kindly note that the information I provide may not be guaranteed for accuracy. How may I help you? También hablo español y otros idiomas

    Virtual Assistant is thinking... ...
  • Skip to content
    Enable Notifications OK No thanks
    NULL